Cutting edge: IL-36 receptor promotes resolution of intestinal damage

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 34-38

  Medina Contreras, Oscar ^a,f   Harusato, Akihito ^a   Nishio, Hikaru ^b,g   Flannigan, Kyle L ^a   Ngo, Vu ^a   Leoni, Giovanna ^b,h   Neumann, Philipp Alexander ^b,i   Geem, Duke ^a,b   Lili, Loukia N ^b   Ramadas, Ravisankar A ^c,j   Chassaing, Benoit ^a   Gewirtz, Andrew T ^a   Kohlmeier, Jacob E ^b   Parkos, Charles A ^b   Towne, Jennifer E ^e,k   Nusrat, Asma ^b,d   Denning, Timothy L ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e AMGEN INC   (United States)

^f INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^g Research Center   (Japan)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j MERCK RESEARCH LABORATORIES   (United States)

^k JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; INTERLEUKIN 22; INTERLEUKIN 36 ALPHA; INTERLEUKIN 36 BETA; INTERLEUKIN 36 GAMMA; INTERLEUKIN 36 RECEPTOR; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG; AROMATIC HYDROCARBON RECEPTOR; DEXTRAN SULFATE; IL1F9 PROTEIN, MOUSE; INTERLEUKIN 1; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; INTERLEUKIN-36 RECEPTOR, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; LEUKOCYTE FUNCTION; LYMPHOCYTE COUNT; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; T LYMPHOCYTE; WOUND HEALING; AGONISTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; COLON; GENETICS; HELICOBACTER HEPATICUS; IMMUNOLOGY; INFLAMMATION; INJURIES; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOGENICITY; PATHOLOGY;

ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; HELICOBACTER HEPATICUS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1; INTERLEUKINS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, INTERLEUKIN; WOUND HEALING;

EID: 84953231157     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501312     Document Type: Article

References (22)

1. Abraham, C., and R. Medzhitov. 2011. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140: 1729-1737.
2. Bamias, G., D. Corridoni, T. T. Pizarro, and F. Cominelli. 2012. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 59: 451-459.
3. Takagi, H., T. Kanai, A. Okazawa, Y. Kishi, T. Sato, H. Takaishi, N. Inoue, H. Ogata, Y. Iwao, K. Hoshino, et al. 2003. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastro- enterol. 38: 837-844.
4. Dupaul-Chicoine, J., G. Yeretssian, K. Doiron, K. S. Bergstrom, C. R. McIntire, P. M. LeBlanc, C. Meunier, C. Turbide, P. Gros, N. Beauchemin, et al. 2010. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32: 367-378.
5. Zaki, M.H., K.L. Boyd, P. Vogel, M.B. Kastan, M. Lamkanfi, and T. D. Kanneganti. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32: 379-391.
6. Bersudsky, M., L. Luski, D. Fishman, R. M. White, N. Ziv-Sokolovskaya, S. Dotan, P. Rider, I. Kaplanov, T. Aychek, C. A. Dinarello, et al. 2014. Non-redundant properties of IL-1a and LL-1|3 during acute colon inflammation in mice. Gut 63: 598-609.
7. Villani, A. C., M. Lemire, G. Fortin, E. Louis, M. S. Silverberg, C. Collette, N. Baba, C. Libioulle, J. Belaiche, A. Bitton, et al. 2009. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41: 71-76.
8. Dinarello, C. A. 2013. Overview of the interleukin-1 family of ligands and receptors. Semin. Immunol. 25: 389-393.
9. McNamee, E. N., J. C. Masterson, P. Jedlicka, M. McManus, A. Grenz, C. B. Collins, M. F. Nold, C. Nold-Petry, P. Bufler, C. A. Dinarello, and J. Rivera-Nieves. 2011. Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Scl USA 108: 16711-16716.
10. Gabay, C., and J. E. Towne. 2015. Regulation and function ofinterleukin-36 cy-tokines in homeostasis and pathological conditions. J. Leukoc. Biol. 97: 645-652.
11. Garlanda, C., C. A. Dinarello, and A. Mantovani. 2013. The interleukin-1 family: back to the future. Immunity 39: 1003-1018.
12. Chassaing, B., O. Koren, J. K. Goodrich, A. C. Poole, S. Srinivasan, R. E. Ley, and A. T. Gewirtz. 2015. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519: 92-96.
13. Medina-Contreras, O., D. Geem, O. Laur, I. R. Williams, S. A. Lira, A. Nusrat, C. A. Parkos, and T. L. Denning. 2011. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 121: 4787-4795.
14. Zindl, C. L., J. F. Lai, Y. K. Lee, C. L. Maynard, S. N. Harbour, W. Ouyang, D. D. Chaplin, and C. T. Weaver. 2013. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl. Acad. Sci. USA 110: 12768-12773.
15. Kullberg, M. C., D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, and A. Sher. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203: 2485-2494.
16. Leoni, G., A. Alam, P. A. Neumann, J.D. Lambeth, G. Cheng, J. McCoy, R. S. Hilgarth, K. Kundu, N. Murthy, D. Kusters, et al. 2013. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J. Clin. Invest. 123: 443-454.
17. Rivollier, A., J. He, A. Kole, V. Valatas, and B. L. Kelsall. 2012. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209: 139-155.
18. Leoni, G., P. A. Neumann, R. Sumagin, T. L. Denning, and A. Nusrat. 2015. Wound repair: role of immune-epithelial interactions. Mucosal Immunol. 8: 959-968.
19. Mizoguchi, A. 2012. Healing of intestinal inflammation by IL-22. Inflamm. Bowel Dis. 18: 1777-1784.
20. Qiu, J., J. J. Heller, X. Guo, Z. M. Chen, K. Fish, Y. X. Fu, and L. Zhou. 2012. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36: 92-104.
21. Monteleone, I., A. Rizzo, M. Sarra, G. Sica, P. Sileri, L. Biancone, T. T. Mac-Donald, F. Pallone, and G. Monteleone. 2011. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141: 237-248, 248.e1. doi:10.1053lj.gastro.2011.04.007
22. Serhan, C. N., S. Yacoubian, and R. Yang. 2008. Anti-inflammatory and pro-resolving lipid mediators. Annu. Rev. Pathol. 3: 279-312.